Cleerly
AI-powered heart disease diagnostics
- 201-500 employees
- Healthcare
- B2B
- Artificial Intelligence
- MedTech
- Central Business District, Denver, CO
Jump to section
Company mission
To eliminate heart attacks by creating a new standard of care for the diagnosis of heart disease.
102% employee growth in 12 months
Our take
Traditional heart disease evaluation methods, such as a coronary angiogram, can be invasive - a catheter is threaded through the arm or leg to reach the heart, where it injects dye into its arteries so X-ray images can capture how blood flows through the vessels.
Though serious complications from the procedure are rare, they potentially include injury to the artery, an allergic reaction or kidney damage from the dye, as well as heart attack or stroke. This is a problem that Cleerly is trying to solve by measuring this plaque through AI-powered imaging which analyzes non-invasive coronary CT scans.
The company's continued success and growth, marked by recent funding, reflect the immense potential of its AI-driven imaging technology. With strong financial backing, the company is well-positioned to revolutionize heart disease screening and expand its market reach. As Cleerly moves closer to gaining full regulatory approval and broader coverage, its innovative approach to early detection could be a transformative impact on healthcare, making it an exciting company to watch in coming years.
Kirsty
Company Specialist at Welcome to the Jungle
Benefits
- Comprehensive benefits package to support your health, growth, and work-life balance
- Choose from a variety of medical, dental, and vision plans that suit your needs
- We also offer an Employee Assistance Program (EAP)
- Flexible self-managed PTO
- Company holidays, including the week between Christmas Eve & New Year's Day, so you can recharge
- 401K with company match
- Generous parental leave
- Monthly stipends for WiFi/Internet and wellness
- Support your professional growth with annual stipends for learning and development
- Home office support
Company values
- Humility: Be a servant leader
- Excellence: Deliver world-changing results
- Accountability: Do what you say; expect the sam from others
- Remarkable: Inspire & innovate with impact
- Teamwork: Together we win
Funding (last 2 of 6 rounds)
Dec 2024
$106m
SERIES C
Jul 2022
$223m
SERIES C
Total funding: $417.8m
This company has top investors
Leadership
Dr. James Min
(Founder & CEO)Former Professor of Radiology and Medicine in Cardiology at Weill Cornell Medical College and the New York-Presbyterian Hospital. Former Director of the Dalio Institute of Cardiovascular Imaging.